Domains targeting keyword patients acquisition services
Keyword patients acquisition services was used in the provided list of websites.
Number of websites/domains displayed: 7
Results found: 7
Similar searches:
Websites discovered:
Medical Marketing | Medical Call Centerhttp://pageoverview.com/website-report/redspotinteractive.com
RSI optimizes the marketing and entire patient acquisition for medical practices by generating high quality leads and converting them to new patients.
- Expected expiration: September 24th in 2018
- Creation date: September 24th in 2012
- Renew date: September 25th in 2016
- Google Analytics: 2722615-3
- Google Plus Account: 103073054236361159752
Global Pharmaceutical Group | Alliance Pharmahttp://pageoverview.com/website-report/alliancepharmaceuticals.com
Our expertise lies in the acquisition and licensing of pharmaceutical and healthcare products and delivering these to patients
- Expected expiration: November 8th in 2017
- Creation date: November 8th in 2002
- Renew date: October 9th in 2015
- Google Analytics: 22141764-1
TIVICAY (dolutegravir), TRIUMEQ (abacavir/dolutegravir/lamivudine)http://pageoverview.com/website-report/tivicay.com
Information about TIVICAY and TRIUMEQ for healthcare professionals and patients prescribed TIVICAY or TRIUMEQ
- Expected expiration: December 20th in 2017
- Creation date: December 20th in 2006
- Renew date: December 21st in 2016
Florida Dental Board Preps., Inc.http://pageoverview.com/website-report/boardpreps.com
- Expected expiration: April 26th in 2018
- Creation date: April 26th in 2000
- Renew date: July 10th in 2017
Genentech: Pegasys® (peginterferon alfa-2a) - Information for Patientshttp://pageoverview.com/website-report/pegasys.com
Find important safety information and patient resources for all of our currently marketed medicines.
- Expected expiration: March 30th in 2019
- Creation date: March 29th in 1997
- Renew date: April 1st in 2017
- Google Analytics: 22947831-2
- Google Plus Account: +genentech
ZEVALIN® (ibritumomab tiuxetan)http://pageoverview.com/website-report/zevalin.com
Information for U.S. patients and healthcare professionals about ZEVALIN® (ibritumomab tiuxetan) injection for intravenous use
- Expected expiration: May 7th in 2018
- Creation date: May 7th in 1999
- Renew date: June 1st in 2016
- Google Analytics: 12595498-2
Roche - Doing now what patients need nexthttp://pageoverview.com/website-report/roche.com
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
- Expected expiration: April 18th in 2022
- Creation date: April 17th in 1992
- Renew date: December 23rd in 2013
- Google Analytics: 32005-3